Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring
The purpose of this proposed Notice of Funding Announcement (NOFO) is to support development of biomarkers or clinical outcomes derived from digital health technology (DHT) for use in clinical trials for remote monitoring as primary or secondary endpoints. To improve clinical impact, increase statistical feasibility, a
| Agency | National Institutes of Health |
|---|---|
| Status | Posted |
| Opportunity number | PAR-25-170 |
| Posted date | 11/13/2024 |
| Application deadline | Jun 22, 2026 12:00:00 AM EDT |
| Award ceiling | none |
| Award floor | none |
| Who can apply | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); R |
| Assistance Listing (CFDA) | 93.399, 93.853, 93.866 |
| Description | The purpose of this proposed Notice of Funding Announcement (NOFO) is to support development of biomarkers or clinical outcomes derived from digital health technology (DHT) for use in clinical trials for remote monitoring as primary or secondary endpoints. To improve clinical impact, increase statistical feasibility, and promote standardization, applicants will be expected to develop and test the digitally derived assessments in populations from at least three different diseases or conditions. Partnerships with non-profit patient advocacy organizations will be required. |
| Agency contact | grantsinfo@nih.gov |
| Official listing | https://www.grants.gov/search-results-detail/357087 |